|
| 3-(3-(4'-Bromo(1,1'-biphenyl)-4-yl)-3-oxo-1-phenylpropyl)-4-hydroxy-2-benzopyrone |
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun |
|
| Alnustone |
|
Streptococcus |
Pneumolysin |
Preclinical (in vivo) |
Zhang C, et al. 2022. Fitoterapia |
|
| Curcumin |
|
Acinetobacter
Bacillus
Clostridium
Enterococcus
Pseudomonas |
BfmRS
Biofilm
Collagenase
Biofilm
Quorum sensing |
Preclinical (in vitro)
Preclinical (in vitro)
Preclinical (in vitro)
Preclinical (in vitro)
Preclinical (in vitro) |
Raorane CJ, et al. 2019. Front Microbiol
Fernandes S, et al. 2023. Food Res Int
Nitulescu G, et al. 2022. Life (Basel)
Oda DF, et al. 2019. Int Endod J
|
|
| [2,4-Dihydroxy-3-(3-methyl-2-buten-1-yl)phenyl][(1R,2S,6S)-6-(2,4-dihydroxyphenyl)-2-[4-[(1E)-2-(2,4-dihydroxyphenyl)ethenyl]-2,6-dihydroxyphenyl]-4-methyl-3-cyclohexen-1-yl]methanone |
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Mascarello A, et al. 2013. PLoS One |
|
| Rottlerin |
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Sambanthamoorthy K, et al. 2014. Biofouling |
|
| 4,4-difluoro-1,7-dihydroxy-1,7-diphenylhepta-1,6-diene-3,5-dione |
|
Yersinia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Kauppi AM, et al. 2003. Chem Biol |
|
| 4-[(E)-2-[5-[(E)-2-[4-(dimethylamino)phenyl]ethenyl]-2-methyltetrazolo[1,5-a]pyrimidin-8-ium-7-yl]ethenyl]-N,N-dimethylaniline |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Hu X, et al. 2013. Bioorg Med Chem Lett |
|
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
